Amgen Inc (AMGN)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account

Sell

$316.00

Buy

$321.24

arrow-up$0.36 (+0.11%)

Prices updated at 13 Dec 2025, 00:58 EST

Prices minimum 15 mins delay

Prices in USD

Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Drug Manufacturers - General

Chairman

Mr. Robert A. Bradway

CEO

Mr. Robert A. Bradway

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

28,000

Head office

One Amgen Center Drive

Thousand Oaks

United States

91320-1799

+1 805 447-1000

investor.relations@amgen.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Ms. Amy E. Miles Independent Director	0.14m
Mr. Charles M. Holley, Jr Independent Director	-
Ms. Ellen J. Kullman Independent Director	0.15m
Mr. Robert A. Eckert Lead Independent Director	0.21m
Mr. Robert A. Bradway Chairman of the Board, President and Chief Executive Officer	1.87m
Professor Dr. Tyler E. Jacks, PhD Independent Director	0.14m
Mr. Jonathan P. Graham Executive Vice President, General Counsel and Secretary	-
Mr. Greg C. Garland Independent Director	0.16m
Mr. Murdo Gordon Executive Vice President, Global Commercial Operations	1.20m
Dr. James E. Bradner, M.D. Executive Vice President, Research and Development	1.21m
Mr. Esteban Santos Executive Vice President, Operations	-
Dr. Wanda M. Austin Independent Director	0.14m
Dr. Brian J. Druker, M.D. Independent Director	0.14m
Dr. David M. Reese, M.D. Executive Vice President and Chief Technology Officer	1.27m
Mr. Peter H. Griffith Executive Vice President and Chief Financial Officer	1.13m
Ms. Nancy A. Grygiel Senior Vice President and Chief Compliance Officer	-
Dr. S. Omar Ishrak Independent Director	-
Ms. Rachna Khosla Senior Vice President, Business Development	-
Mr. Derek Miller Senior Vice President, Human Resources	-
Mr. Michael V. Drake Independent Director	-
Mr. Matthew C. Busch Vice President, Finance and Chief Accounting Officer	-
Ms. Mary E. Klotman Independent Director	0.08m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Vanguard Group Inc	53,711,570
BlackRock Inc	46,034,432
Capital Research and Management Company	41,575,511
State Street Corp	29,304,093
Capital Group	25,873,256

Director dealings

Date chevron-l-regular chevron-r-regular	Action
05 Dec 2024	-
02 Dec 2024	-
02 Dec 2024	-
02 Dec 2024	-
05 Nov 2024	-
05 Nov 2024	-
04 Nov 2024	-
04 Nov 2024	-
09 Aug 2024	-
09 Aug 2024	-
31 Jul 2024	-
31 May 2024	-
31 May 2024	-
31 May 2024	-
31 May 2024	-
31 May 2024	-
31 May 2024	-
31 May 2024	-
31 May 2024	-
31 May 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.